Skip to Content

Octagam Approval History

FDA Approved: Yes (First approved May 21, 2004)
Brand name: Octagam
Generic name: immune globulin intravenous (human)
Dosage form: Injection
Company: Octapharma AG
Treatment for: Primary Immunodeficiency Syndrome

Octagam (immune globulin intravenous (human)) is a ready-to-use immunoglobulin intravenous (IGIV) product indicated for the treatment of primary immunodeficiency diseases.

Development History and FDA Approval Process for Octagam

DateArticle
May 21, 2004Approval Octagam Octapharma AG - Treatment for Primary Immunodeficiency Diseases

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide